We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Genomic Sequencing Identifies Deadly Bloodstream Infection

By LabMedica International staff writers
Posted on 06 Apr 2016
The differentiation between fungal infections originating from a single contaminated point source and those independently acquired from the environment is often difficult.

Despite modern advances in technology to control fungal contamination in clinical settings, fungi are continuously implicated in clusters or outbreaks of infections particularly among immunosuppressed patients. More...


An international team of scientists led by those at the Centers for Disease Control and Prevention (Atlanta, GA, USA) used whole-genome sequence typing (WGST) to investigate an outbreak of Sarocladium kiliense bloodstream infections (BSI) associated with receipt of contaminated anti-nausea medication among oncology patients in Colombia and Chile during 2013–2014. There were 25 outbreak isolates, 18 from patients and 7 from medication vials, and 11 control isolates unrelated to the outbreak, were subjected to WGST to elucidate a source of infection.

The 36 DNA samples were prepared for Illumina sequencing (Illumina, San Diego, CA, USA) by using the KAPA Biosystems Library Preparation with Standard PCR kit (KAPA Biosystems; Wilmington, MA, USA) protocol with a modified 8-bp index. All 36 libraries were sequenced to a read length of 100 bp on the Illumina HiSeq 2500 system. All outbreak isolates were nearly indistinguishable, less than five single-nucleotide polymorphisms, and more than 21,000 single-nucleotide polymorphisms were identified from unrelated control isolates, suggesting a point source for this outbreak.

The authors concluded that their study highlighted the utility of advanced molecular methods to investigate outbreaks involving rare fungi. Next-generation sequencing and bioinformatics analyses will remain critical molecular epidemiology tools in such epidemiologic investigations. David Engelthaler, PhD, Director of Programs and Operations for the Translational Genomic Research Institute (Flagstaff, AZ, USA) and coauthor of the study said, “The use of whole-genome sequence typing (WGST) to investigate fungal outbreaks has become integral to epidemiologic investigations. Our WGST analysis demonstrated that the patient isolates from Chile and Colombia were nearly genetically indistinguishable from those recovered from the unopened medication vials, indicating the likely presence of a single-source infection.” The study was published in the March 2016, issue of the journal Emerging Infectious Diseases.

Related Links:

Centers for Disease Control and Prevention
Illumina 
Translational Genomic Research Institute



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more

Industry

view channel
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.